Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin and Tenofovir for Chronic Hepatitis B
NCT03759782Phase 3Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in Chronic Hepatitis B (CHB), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
ribavirin
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03759782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03759782.